Topical antibacterial and combined therapy of pyoderma and complicated atopic dermatitis with mupirocin


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅存取

详细

Clinical efficacy of topical mupirocin in pyoderma and atopic dermatitis complicated with bacterial infection was established.

作者简介

O Elisyutina

Institute of Immunology

Email: el-olga@yandex.ru
Moscow, Russia

E Fedenko

Institute of Immunology

Moscow, Russia

O Shtyrbul

Institute of Immunology

Moscow, Russia

参考

  1. Масюкова С.А., Гладько В.В. Устинов М.В. и соавт. Бактериальные инфекции кожи и их значение в клинической практике дерматолога. Cons. Med. 2004, № 3, с. 180-186.
  2. Новосёлов В.С., Плиева Л.Р. Пиодермии. Рос. Аллергол. Журн. 2004, № 5, с. 33-38.
  3. Казначеева Л.Ф., Молокова А.В., Казначеев К.С. Профилактика вторичного инфицирования кожи у детей с атопическим дерматитом. Рациональная терапия и уход. Рос. Аллергол. Журн. 2005, № 3, с. 82-86.
  4. Аллергология и иммунология: национальное руководство. Под ред. Р.М. Хаитова, Н.И. Ильиной. М., «ГЭОТАР-Медиа». 2009, 656 с.
  5. Wolf R., Wolf D. Abnormal epidermal barrier in the pathogenesis of atopic dermatitis. Clin. Dermatol. 2012, v. 30 (3), p. 329-334.
  6. Breuer K., Kapp A., Werfel T. Bacterial infections and atopic dermatitis. Allergy. 2001, v. 56, p.1034-1041.
  7. Ong P.Y., Ohtake T., Brandt C. et al. Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N. Engl. J. Med., 2002, v. 347, p. 1199-2000.
  8. Arikawa J. Decreased levels of sphingosine, a natural antimicrobial agent, may be associated with vulnerability of the stratum corneum from patients withatopic dermatitis to colonization by Staphylococcus aureus. J. Invest. Dermatol. 2002, v. 119 (2), p. 433-439.
  9. Bieber Т. Atopic Dermatitis. Mechanisms of Disease. N. Engl. J. Med. 2008, v. 358, p. 1483-1494.
  10. Hauk D.J., Hamid Q.A., Chrousos G.P., Leung D.Y.M. Induction of corticosteroid insensitivity in human PBMCs by microbial superantigens. J. Allergy Clin. Immunolog. 2000, v. 105 (4), p. 782-787.
  11. Akdis C., Akdis M., Bieber T. et al. Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/ American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Report. J. Allergy Clin. Immunol. 2006, v. 118, p. 152-169.
  12. Van Rijen M., Bonten M., Wenzel R., Kluytmans J. Mupirocin ointment for preventing Staphylococcus aureus infections in nasal carriers Cochrane Database Syst Rev. 2008, v. 8 (4), CD006216.
  13. Gong J.Q., Lin L., Lin T. et al. Skin colonization by Staphylococcus aureus in patients with eczema and atopic dermatitis and relevant combined topical therapy: a double-blind multicentre randomized controlled trial. Br. J. Dermatol. 2006, v. 155 (4), p. 680-687.
  14. Breuer K., Haussler S., Kapp A., Werfel T. Staphylococcus aureus: colonizing features and influence of an antibacterial treatment in adults with atopic dermatitis. Br. J. Dermatol. 2002, v. 147 (1), p. 55-61.
  15. Lever R. Staphylococcal colonization in atopic dermatitis and the effect of topical mupirocin therapy. Br. J. Dermatol. 1988, v. 119 (2), p. 189-198.
  16. Савицкая Л.Н. Клинико-иммунологические особенности патогенеза, течения, терапии фурункулеза в Казахстане (клинико-экспериментальное исследование). Диссертация д-ра мед. наук. Семипалатинск. 1987.
  17. Hanifin J., Rajka G. Diagnostic features of atopic dermatitis. Acta Derm. Venerol. (Stockh). 1980, v. 114 (Suppl), p. 44-47.
  18. Stadler J.F., Taieb A. Severity scoring of atopic dermatitis: the SCORAD index. Consensus report ofthe European task force on atopic dermatitis. Dermatology. 1993, v. 186, p. 23-31.

版权所有 © Pharmarus Print Media, 2012

##common.cookie##